744202-33-3 Usage
Uses
Used in Organic Synthesis:
(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole-2-yl)methanamine is used as a protecting group in organic synthesis for [application reason]. The trimethylsilyl group can be selectively removed under mild conditions, allowing for controlled reactions and the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole-2-yl)methanamine is used as a building block for the development of new pharmaceuticals for [application reason]. The imidazole ring and primary amine functional group may contribute to the compound's biological activity, making it a candidate for drug discovery and design.
Used in Chemical Research:
(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole-2-yl)methanamine is used as a research tool in chemical studies for [application reason]. Its unique structure allows scientists to investigate the properties and reactivity of the imidazole ring and the trimethylsilyl group, furthering our understanding of these functional groups and their applications in chemistry.
Used in Application Industry:
(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole-2-yl)methanamine is used as [application type] for [application reason] in the [Application Industry]. The specific use of (1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole-2-yl)methanamine in a particular industry is determined by its unique properties and the needs of that industry.
Check Digit Verification of cas no
The CAS Registry Mumber 744202-33-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,4,2,0 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 744202-33:
(8*7)+(7*4)+(6*4)+(5*2)+(4*0)+(3*2)+(2*3)+(1*3)=133
133 % 10 = 3
So 744202-33-3 is a valid CAS Registry Number.
744202-33-3Relevant academic research and scientific papers
HETEROCYCLIC NON-PEPTIDE GNRH ANTAGONISTS
-
Page/Page column 38; 83, (2008/06/13)
A compound of formula (I): wherein either B is absent and A and Z are the same or different and are each hydrogen, halogen, alkyl, hydroxy, alkoxy,-CN,-C(Rc)2OH,-N(Rd)C(=X)Rc,-C(=X)N(Rc)(Rd),-S(O)m-Rc,-N(Rc)(Rd)S(O)2,-S(O)2N(R c)(Rd),-N(Re)2, aryl optionally substituted with Ra or-O-aryl optionally substituted with Ra; or B is present and is-(CH2)n-,-C(Rb)2-or-O-, or B taken together with A or Z can be-C=C(Rb)-,-C(Rb)=C-,-CH2-CH(R b)-or-CH(Rb)-CH2-; D is-O-or-S(O) m,-; E is a bond or is-(CH2)n-,-N(R d)-,-(CH2)nN(Rd)-or-N(R d)(CH2)n-; F is-C(=X)-; G is-(CH2 )n-,-N(Rd)-,-(CH2)nN(R d)-or-N(Rd)(CH2)n; J is a bond,-O-,-N(RC)C(=X)-,-C(=X)N(Rc)-,-S(O)m,-,-N(Rc)S(O)m-,-S(O)nN(Rc)-,-N(Re)-or-N(Rg)(Rh); K is a bond, alkylene, cycloalkylene, cycloalkenylene, arylene, heterocycloalkylene, heterocycloalkylene or heteroarylene; and L is hydrogen or a terminal group; has therapeutic utility.
A novel synthetic approach towards 2-guanidinomethyl-4(5)- sulfamoylimidazoles
Price, Steve,Bull, Richard,Cramp, Sue,Gardan, Sophie,Van Den Heuvel, Marco,Neighbour, David,Osbourn, Susan E.,De Esch, Iwan J.P.,Buenemann, Christoph L.
, p. 5581 - 5583 (2007/10/03)
A library of 2-guanidinomethyl-4(5)-sulfamoylimidazoles was synthesised in a convergent manner by introducing a sulfonyl chloride group via a trianion electrophilic sulfinylation of suitably protected 2-guanidinomethyl imidazoles.
